title: Endovascular repair of blunt traumatic thoracic aortic injuries: seven-year single-center experience.
abstract: OBJECTIVE
  Thoracic endovascular aortic repair (TEVAR) for acute blunt thoracic aortic injury has good early and mid-term results.
  
  
  METHODS
  Single-center retrospective 7-year review from January 2001 to December 2008.
  
  
  METHODS
  Urban tertiary care hospital.
  
  
  METHODS
  Twenty-four consecutive patients with acute blunt thoracic aortic injury treated with TEVAR.
  
  
  METHODS
  Procedure-related mortality, stroke, or paraplegia; injury severity score; and complications.
  
  
  RESULTS
  Among the 24 treated patients (mean age, 41 years; range, 20-71 years), the mean injury severity score was 43 (range, 25-66). Thoracic endovascular aortic repair was successful in treating the aortic injury in all patients and there were no instances of procedure-related death, stroke, or paraplegia. Access to the aorta was obtained through an open femoral/iliac approach (n = 7) or an entirely percutaneous groin approach (n = 17). Systemic heparin was not used in 84% of cases. Two access complications (8%) occurred, requiring an iliofemoral bypass in one patient and a thrombectomy in another. One patient required secondary intervention for device collapse, which was treated successfully with repeat endografting. There have been no delayed device failures or complications among the entire cohort at mid-term follow-up.
  
  
  CONCLUSIONS
  Thoracic endovascular aortic repair, via a percutaneous groin approach and without systemic anticoagulation, for blunt thoracic aortic injury can be performed safely with low periprocedural mortality and morbidity.
authors.affiliation: Division of Vascular Surgery, Northwestern University, 676 N St Clair, Chicago, IL 60611, USA.
authors.forename: Manuel
authors.initials: M
authors.lastname: Garcia-Toca
authors.forename: Peter A
authors.initials: PA
authors.lastname: Naughton
authors.forename: Jon S
authors.initials: JS
authors.lastname: Matsumura
authors.forename: Mark D
authors.initials: MD
authors.lastname: Morasch
authors.forename: Melina R
authors.initials: MR
authors.lastname: Kibbe
authors.forename: Heron E
authors.initials: HE
authors.lastname: Rodriguez
authors.forename: William H
authors.initials: WH
authors.lastname: Pearce
authors.forename: Mark K
authors.initials: MK
authors.lastname: Eskandari
mesh_terms: D000328:Adult; D000368:Aged; D017130:Angioplasty / Q000009:adverse effects / Q000379:methods / Q000401:mortality; D001013:Aorta, Thoracic / Q000293:injuries* / Q000601:surgery*; D016913:Blood Component Transfusion; D019917:Blood Vessel Prosthesis Implantation; D002641:Chicago / Q000453:epidemiology; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006786:Hospitals, Urban / Q000706:statistics & numerical data*; D006801:Humans; D015601:Injury Severity Score; D008297:Male; D008875:Middle Aged; D009104:Multiple Trauma / Q000175:diagnosis / Q000601:surgery; D010264:Paraplegia / Q000209:etiology; D012189:Retrospective Studies; D015607:Stents; D020521:Stroke / Q000209:etiology; D016896:Treatment Outcome; D014949:Wounds, Nonpenetrating / Q000209:etiology / Q000601:surgery*; D055815:Young Adult